Table 1 Clinical data of colorectal cancer (CRC) patients
From: Promoter methylation correlates with reduced NDRG2expression in advanced colon tumour
| Â | CRC n = 30 (%) |
|---|---|
Age (yrs): | Â |
Mean (± SD) | 59 ± 14 |
Sex: | Â |
Male/Female | 15/15 |
Tumour location: | Â |
Ascending colon | 7 (23%) |
Transverse colon | 2 (7%) |
Descending colon | 4 (13%) |
Sigmoid colon | 8 (27%) |
Rectum | 4 (13%) |
Rectum-Sigmoid colon | 5 (17%) |
AJCC stage: | Â |
0 | 1 (3%) |
I | 3 (10%) |
IIa | 8 (27%) |
IIIb | 3 (10%) |
IIIc | 1 (3%) |
IV | 14 (47%) |
Age (yrs): | Â |
Mean age <50 | 41 ± 7 |
CRC: | Â |
Familiar/Sporadic | 1/8 |
Tumour location: | Â |
Ascending colon | 1 (11%) |
Descending colon | 2 (22%) |
Sigmoid colon | 4 (45%) |
Rectum | 1 (11%) |
Rectum-Sigmoid colon | 1 (11%) |
AJCC stage: | Â |
I | 1 (11%) |
IIIb | 2 (22%) |
IIIc | 1 (11%) |
IV | 5 (55%) |
Age (yrs): | Â |
Mean age >50 | 66 ± 9 |
CRC: | Â |
Familiar/Sporadic | 8/13 |
Tumour location: | Â |
Ascending colon | 6 (29%) |
Transverse colon | 2 (9%) |
Descending colon | 2 (9%) |
Sigmoid colon | 4 (19%) |
Rectum | 3 (15%) |
Rectum-Sigmoid colon | 4 (19%) |
AJCC stage: | Â |
0 | 1 (5%) |
I | 2 (9%) |
IIa | 8 (38%) |
IIIb | 1 (5%) |
IV | 9 (43%) |